Wellvone 750 mg/5 ml, 225 ml


Wellvone contains atovaquone and is indicated for the treatment of Pneumocystis carinii pneumonia (PCP).

More info

Wellvone 750 mg/5 ml, oral suspension

Wellvone suspension contains atovaquone, an antiprotozoal medicine. It is used to treat a type of pneumonia caused by Pneumocystis carinii.

Pneumocystis carinii is a parasite that can lie dormant in the airways unless the body’s immune system becomes weakened, for example in human immunodeficiency virus (HIV) infection. This can lead to Pneumocystis carinii pneumonia (PCP).

More Information
Nr. 21070
Registration number Human
Brand Various
Chilled No
Active Ingredient atovaquone
Target species Human
Units per outer box 0
© 2020 Grovet B.V. All rights reserved.